Covidien Pays Medrad $17M, Ending Multiple Suits
Covidien Ltd. has agreed to pay Medrad Inc. $17 million to resolve patent infringement litigation over injection systems used with magnetic resonance imaging systems....To view the full article, register now.
Already a subscriber? Click here to view full article